Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14958-14964
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14958
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14958
Table 1 Clinical and biochemical characteristics of samples in the first part of the study n (%)
| Training set | Blind test set | P-value1 | |||||||
| Malignant | Benign | Healthy | P-value | Malignant | Benign | Healthy | P-value | ||
| Sex | |||||||||
| Male | 13 (56.52) | 10 (55.56) | 12 (60.00) | 0.957 | 10 (45.45) | 5 (50.00) | 5 (33.33) | 0.662 | 0.665 |
| Female | 10 (43.48) | 8 (44.44) | 8 (40.00) | 12 (54.55) | 5 (50.00) | 10 (66.67) | |||
| Age (yr, mean ± SD) | 62.61 ± 12.71 | 60.61 ± 8.51 | 55.50 ± 13.13 | 0.145 | 65.14 ± 13.02 | 59.10 ± 14.15 | 63.07 ± 12.60 | 0.402 | 0.18 |
| Pathology | |||||||||
| Ductal adenocarcinoma | 23 (100.00) | 22 (100.00) | |||||||
| Mucinous cystadenoma | 7 (38.89) | 2 (20.00) | |||||||
| Solid pseudopapillary tumor | 4 (22.22) | ||||||||
| Insulinoma | 3 (16.67) | 3 (30.00) | |||||||
| Serous cystadenoma | 2 (11.11) | 3 (30.00) | |||||||
| Intraductal papillary mucinous tumor | 2 (11.11) | 2 (20.00) | |||||||
| CA19-9 (U/mL, mean ± SD) | 10.66 ± 8.92 | 11.94 ± 6.93 | 9.67 ± 6.94 | 0.382 | 12.45 ± 9.69 | 15.51 ± 11.60 | 10.00 ± 8.27 | 0.557 | 0.667 |
Table 2 Statistics of four candidate biomarkers for screening pancreatic cancer (C) from healthy individuals (H)
| Intensity in malignant disease (n= 23) | Intensity in healthy individuals (n= 20) | ||
| m/z | (mean ± SD) | (mean ± SD) | P-value |
| 5870.055 | 357.47 ± 137.81 | 688.97 ± 191.35 | 2.61E-07 |
| 6468.245 | 363.30 ± 265.95 | 1107.33 ± 356.79 | 3.84E-07 |
| 7777.958 | 2582.30 ± 1399.85 | 453.67 ± 726.81 | 5.62E-07 |
| 4291.792 | 669.14 ± 497.32 | 1562.50 ± 413.97 | 3.95E-06 |
Table 3 Predicted results of patterns in the study
| n | Training set | Blind test set | ||||
| Specificity | Sensitivity | Specificity | Sensitivity | PPV | ||
| Pattern 1 | 4 | 100% | 100% | 86.7% | 86.4% | 86.4% |
| Pattern 2 | 6 | 83.3% | 91.3% | 70.0% | 77.3% | 85.0% |
Table 4 Statistics of six candidate biomarkers for screening pancreatic cancer (C) from benign tumors (B)
| Intensity in malignant disease (n= 23) | Intensity in benign disease (n= 18) | ||
| m/z | (mean ± SD) | (mean ± SD) | P-value |
| 4122.616 | 762.41 ± 314.68 | 1541.63 ± 453.43 | 5.17E-06 |
| 3964.253 | 211.84 ± 118.31 | 875.93 ± 547.64 | 3.51E-05 |
| 8920.024 | 1574.91 ± 686.01 | 540.98 ± 635.90 | 3.93E-05 |
| 6683.797 | 226.35 ± 94.75 | 1389.22 ± 1308.83 | 1.32E-04 |
| 4163.942 | 272.72 ± 142.38 | 791.27 ± 509.13 | 2.23E-04 |
| 4144.424 | 631.43 ± 392.13 | 2292.02 ± 1801.45 | 3.71E-04 |
- Citation: Jin XL, Xu B, Wu YL. Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology. World J Gastroenterol 2014; 20(40): 14958-14964
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14958.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14958
